Bayer gives up on plan to grow biotech rapeseed in Europe

07/27/2005 | Wall Street Journal, The

Bayer CropScience has canceled plans to grow biotech rapeseed inside the EU, but is not giving up on the crop and may seek to import it instead if it can get the European government's approval. Bayer faced resistance by several EU member states, which are not comfortable with biotech crops in general, with countries retaining the right to ban the crops within their borders. A spokeswoman said Bayer CropScience still plans to try for EU approval to import approved seeds from the U.S. and Canada.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Membership
The Food and Drug Law Institute
Washington, DC
Medical Director - Cataract
Santa Ana, CA
Associate Director, Legal
Merck Sharp & Dohme
Whitehouse Station, NJ
Manager, Compliance
Fremont, CA
Director, Marketing
The Food and Drug Law Institute
Washington, DC